Read + Share
Ochi S, Sonomoto K, Nakayamada S, Tanaka Y, et al. Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat
rheumatoid arthritis patients: from the FIRST Registry. Arthritis Res Ther 2022;24:61.
PMID: 35232462
|
 |
|
Ochi S, Sonomoto K, Nakayamada S, Tanaka Y, et al. Preferable outcome of Janus kinase inhibitors for a group of difficult-to-treat
rheumatoid arthritis patients: from the FIRST Registry. Arthritis Res Ther 2022;24:61.
PMID: 35232462
|
|
|
|